CHINA
N27
Manufacturer/Innovator
Advanced Intermediates, Alimentary Tract and Metabolism, Antiinfectives for Systemic use, Cardiovascular System, Nervous System, Respiratory System, API Contract Manufacturing
Anhui Heryi Pharmaceuticals, established in 2007, is a certified high&new technology enterprise which researches, manufactures and sells drug API & intermediates. Heryi is able to handle reactions including low temperature reaction of liquid nitrogen, high temperature, high pressure hydrogenation ,etc. Major products include anti-allergens, anti-thrombins, anti-oxidants, gastric drugs, anti-virus drugs, antipyretic analgesics, ultraviolet absorb and so on. 90% of products from Heryi are for exportation to regulated markets.
Heryi is affiliated to 4 production bases and 2 R&D centers, with a total of over 500 employees.The production bases include Anhui Heryi Pharmaceutical Co., Ltd, Anhui Shiuyat Pharmaceutical Co., Ltd. and Liaoning Hersin Pharmaceutical Co., Ltd., Heryi-Dasan Pharmaceutical Co.,Ltd. The R&D centers include Heryi R&D center and Hangzhou Xiaobei Pharma Co., Ltd.
Heryi pharma has obtained GMP certificate (Ganciclovir) in 2018; wholly-owned subsidiary Shiuyat pharma has passed API register (Azintamide) and GMP compliance check in 2023. Both Heryi pharma and Shiuyat pharma have obtained the Accreditation certificate of foreign drug manufacturer.
Heryi is affiliated to 4 production bases and 2 R&D centers, with a total of over 500 employees.The production bases include Anhui Heryi Pharmaceutical Co., Ltd, Anhui Shiuyat Pharmaceutical Co., Ltd. and Liaoning Hersin Pharmaceutical Co., Ltd., Heryi-Dasan Pharmaceutical Co.,Ltd. The R&D centers include Heryi R&D center and Hangzhou Xiaobei Pharma Co., Ltd.
Heryi pharma has obtained GMP certificate (Ganciclovir) in 2018; wholly-owned subsidiary Shiuyat pharma has passed API register (Azintamide) and GMP compliance check in 2023. Both Heryi pharma and Shiuyat pharma have obtained the Accreditation certificate of foreign drug manufacturer.
